Civik Thomas
- SEC CIK
- 0001723092
No open-market purchases or sales filed in the past year.
Current role at each company
- PYXS Pyxis Oncology, Inc.CEO & Chairman of the Boardas of Sep 8, 2026
- RPTX Repare Therapeutics Inc.Directoras of Jan 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Civik Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
CEO & Chairman of the Board1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing) | Nov 18 | 1 day | Civik ThomasDirector | PPurchase | +15.7K | $12.74 | +$200.0K | New position15.7K after |
RPTX Repare Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Civik ThomasDirector | PPurchase | +7.50K | $28.08 | +$210.6K | New position7.50K after |